Ambassador Deborah Birx, MD, believes not enough is doing to prepare for future pandemics. What are her recommendations? Find out in this final installment of her interview with Infection Control Today.
After SARS-CoV-2, researchers are concerned about preparing for the next viral outbreak and where the virus will come from. Infectious diseases do not stay isolated for long in modern times because we are a global community. How we prepare for future outbreaks—even pandemics—will require testing, treatment, prevention, and vaccinations worldwide.
Speaking in an exclusive interview with Infection Control Today® (ICT®) Ambassador Deborah Birx, MD, discussed her presentation titled, “COVID-19 USA - Lessons and new tools to improve workplace safety" at the "Frontline Worker Safety in the Age of COVID-19: A Global Perspective” a Health Watch USA Webinar on September 14, 2022. In this final installment of the interview, she also expressed her concerns about how future viruses may spread from more tropical climates to wider areas because of climate change and how the world should prepare for them.
Ambassador Deborah Birx, MD
Birx is a world-renowned medical expert whose long career has focused on clinical and basic immunology, infectious disease, pandemic preparedness, vaccine research, and global health.
She served the United States as an Army Colonel and later, running some of the most high-profile and influential programs at the US Centers for Disease Control and Prevention and US Department of State. Birx served as the White House Coronavirus Response Coordinator during the Trump Administration.
“With increasing temperatures, many of these viruses that were isolated to tropical areas may become prominent, and from what were semi-tropical, or even temperate climates,” Birx told ICT®. “This is a deep concern because as a global population, we have worked so hard to improve treatment to cancer, [and] we've ignored viral diseases, both from their diagnostics and their treatment…we're not making investments for the medium term; we can see that all of these diseases are escalating as climate changes, as the more importantly, as the human population interacts.”
This is the fourth of 4 installments.
The first installment of the interview is here.
The second installment of the interview is here.
The third installment of the interview is here.
Low Vaccination Concerns Highlight Need for Fall and Winter 2023 Vaccination Campaigns
September 28th 2023Cases of COVID-19, RSV, and influenza are expected to rise this fall and winter season; yet, the number of people who plan on getting the vaccines for each of the infections remains low, according to the NFID announcement today.
Evolving Symptomatology: Respiratory Viruses in the Era of COVID-19 Variants
September 27th 2023As COVID-19 restrictions eased up, other respiratory viruses began circulating alongside SARS-CoV-2. It's crucial to identify cases and understand the symptoms of these infections to track the evolution of the virus and what health care workers should look out for.
Poll: What Minimum Educational Requirement Should Infection Preventionists Have?
September 25th 2023Many infection preventionists (IPs) disagree on the minimum requirement to have the IP position. Let Infection Control Today know your opinion. Answer this poll, and send your thoughts to Senior Editor Tori Whitacre Martonicz at tmartonicz@mjhlifesciences.com.
How to Prepare For Possible “Tripledemic” of RSV, Influenza, and SARS-CoV-2
September 25th 2023The interaction between the respiratory viruses SARS-CoV-2, influenza, and RSV, poses ongoing challenges. Personal protective measures, testing, and vaccination are critical components of our strategy to mitigate the impact of these viruses.
2 Clarke Drive
Cranbury, NJ 08512